Studies have also suggested potential roles of lncRNAs as biomarkers in cancer diagnosis such as prostate cancer antigen 3 (PCA3) for prostate cancer and EGFR-AS1 and MIR205HG as predictors of antiepidermal growth-factor receptor drug response [67,68]. This evidence concerns the gene PCA3 and prostate cancer.